Patriarch Kirill urges compatriots to cherish spiritual ties with homelandSociety & Culture December 04, 2:40
Fidel Castro’s funeral to be held in Santiago de CubaWorld December 04, 1:50
38 ceasefire violations by militants reported in Syria in 24 hoursRussian Politics & Diplomacy December 04, 1:23
Boxer Gassiev beats Lebedev to become IBF cruiserweight world champSport December 04, 0:47
Uzbekistan to hold presidential electionWorld December 04, 0:45
Ukraine does not need position of president - TimoshenkoWorld December 03, 23:52
Russian Orthodox Church head arrives in France on pastoral visitSociety & Culture December 03, 23:45
Russia, Turkey should trade in national currencies, Erdogan told PutinWorld December 03, 23:43
Putin wishes success to Thailand's new kingRussian Politics & Diplomacy December 03, 21:08
MOSCOW, April 14 (Itar-Tass) —— The Russian Skolkovo innovation centre’s resident company is developing innovative medicines against AIDS.
“These medicines use an absolutely new mechanism of action. Molecules affect structural protein that is critical for the HIV virus,” Quantum Pharmaceuticals Deputy Director Maxim Kholin said in an exclusive interview with Itar-Tass.
“The mechanism of action has its peculiarities and they allow us to expect our medicines to be less toxic for the human organism than many others now available. This is very important because the development of medicines against HIV is facing two problems: the virus is highly variable and medicines are toxic,” Kholin noted.
“We are continuing research and getting good results,” he added.
“Skolkovo has supported our project and helped us move forward considerably. It’s important to say that the substances have been developed using our own molecular modelling technology, one of the leading technologies in the world. We also actively use this technological platform for developing other antiviral medicines, new cancer medications and antibiotics. We work both on our own and in partnership with leading international research centres,” Kholin said.